11β-HSD1 Antibodies

Santa Cruz Biotechnology delivers a wide array of 11β-HSD1 monoclonal antibodies for research focused on understanding 11β-hydroxysteroid dehydrogenase type 1. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 11β-HSD1 is an essential enzyme responsible for converting cortisone to cortisol, which enables local activation of glucocorticoids within tissues. The enzyme influences numerous physiological processes, including metabolism, stress response, and inflammation. Research has shown that abnormal 11β-HSD1 activity is linked to metabolic disorders, obesity, and various health conditions, highlighting its potential as a therapeutic target. Understanding 11β-HSD1 function and regulation continues to advance medical knowledge in metabolic health and disease treatment. Investigating 11β-HSD1 expression patterns and activity levels provides valuable insights into disease mechanisms and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of 11β-HSD1 and its impact on human health.